BioIVT continues biospecimen buy up with Keystone Biologicals deal

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Fly_dragonfly)
(Image: Getty/Fly_dragonfly)
The provider research models and services, BioIVT, has acquired Hatboro-PA-based Keystone Biologicals, which supplies disease-state plasma, sera, and controls.

BioIVT​ Vice President of Marketing Courtney Noah, PhD, said the acquisition broadens BioIVT’s capabilities in the in vitro diagnostics (IVD) space “by providing expanded control products and Keystone Biologicals’ expertise in the collection of bulk units of disease-state and normal sera and plasma.”

Following the transaction – financial terms of which were not disclosed – Keystone Biologicals will become part of the BioIVT organization.

With the addition, BioIVT will provide ‘comprehensive’ solutions, including remnant biofluids and tissues for early drug development, clinical specimens and point-of-care services for validation studies, and disease-state plasma collected as bulk units to support IVD manufacturing requirements, said Noah.

“When it comes to diagnostic kit development and manufacturing, IVD researchers need a reliable source for control and calibrator plasma and sera,”​ she added.

Little change will be seen in the early phases of integration, though as the companies fully merge, Noah said, “we will be looking to drive operational efficiencies and customer service processes that will serve to enhance the client experience.”

BioIVT – formerly BioreclamationIVT – has made several acquisitions over the last couple years, and standardized its site processes​ to manage clinical trial data at all of its locations.

Related news

Show more

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us


View more